StonvexLoading…
StonvexStonvexStonvexCore line items from KEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $871.93M | $751.30M | $691.80M | $573.96M |
Operating Income | $62.35M | $47.51M | $42.56M | $2.83M |
Net Income | $148.26M | $634.09M | $-210.95M | $349.66M |
EPS (Diluted) | $1.27 | $11.34 | $-4.42 | $5.80 |
Total Assets | $5.38B | $4.21B | $4.11B | $3.77B |
Total Liabilities | $2.20B | $1.55B | $2.04B | $1.48B |
Cash & Equivalents | $1.48B | $1.02B | $696.84M | $535.17M |
Free Cash Flow OCF − CapEx | $167.39M | $-75.59M | $-55.33M | $490.10M |
Shares Outstanding | Not available | Not available | Not available | Not available |